Singular Genomics Systems, Inc.

EDGAR

20 filing records in this dataset, filed from 2021-05-07 to 2024-11-12. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

5% holders (Schedule 13D and 13G)

  • Deerfield Mgmt IV, L.P. 6.62% SCHEDULE 13D/A 12/22/2024
  • Deerfield Private Design Fund IV, L.P. 6.62% SCHEDULE 13D/A 12/22/2024
  • Deerfield Management Company, L.P. 6.62% SCHEDULE 13D/A 12/22/2024

See all insider transactions

Latest quarter

Revenue

406 thousand USD

2024 Q3 · USD

Exact inputs and evidence

Operating margin

-4,450.99%

2024 Q3 · %

Exact inputs and evidence
  • Operating Income: -18071000 USD Source
  • Revenue: 406000 USD Source

Operating cash flow

-19.8 million USD

2024 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -61529000 USD Source
  • Operating Cash Flow: -41741000 USD Source

Free cash flow

-19.8 million USD

2024 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -61529000 USD Source
  • Operating Cash Flow: -41741000 USD Source
  • Capital Expenditure: 33000 USD Source
  • Capital Expenditure: 26000 USD Source
Cash and cash equivalents
52.6 million USD Source
Exact value

52620000 USD

Long-term debt including current maturities
10.3 million USD Derived
Exact inputs and evidence

10332000 USD

Calculated as noncurrent long-term debt plus its current portion.

  • Current portion of long-term debt: 5166000 USD Source
  • Long-term debt: 5166000 USD Source
Shares outstanding
2.51 million shares Source
Exact value

2507171 shares

Reported share-count change

-96.58% · -70.8 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 73343510 shares · 2023-09-30· Source
  • 2507171 shares · 2024-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.67 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Revenue: 2911000 USD · 2023-01-01 – 2023-12-31 Source
  • Revenue: 1830000 USD · 2023-01-01 – 2023-09-30 Source
  • Revenue: 442000 USD · 2024-01-01 – 2024-03-31 Source
  • Revenue: 737000 USD · 2024-04-01 – 2024-06-30 Source
  • Revenue: 406000 USD · 2024-07-01 – 2024-09-30 Source

Net income

-86.3 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Net income: -94820000 USD · 2023-01-01 – 2023-12-31 Source
  • Net income: -71571000 USD · 2023-01-01 – 2023-09-30 Source
  • Net income: -25024000 USD · 2024-01-01 – 2024-03-31 Source
  • Net income: -21254000 USD · 2024-04-01 – 2024-06-30 Source
  • Net income: -16795000 USD · 2024-07-01 – 2024-09-30 Source

Operating cash flow

-80.4 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Operating cash flow: -73647000 USD · 2023-01-01 – 2023-12-31 Source
  • Operating cash flow: -54745000 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -23703000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -41741000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -23703000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -61529000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -41741000 USD · 2024-01-01 – 2024-06-30 Source

Capital expenditure

425 thousand USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Capital expenditure: 970000 USD · 2023-01-01 – 2023-12-31 Source
  • Capital expenditure: 578000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 25000 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 26000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 25000 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 33000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 26000 USD · 2024-01-01 – 2024-06-30 Source

Free cash flow

-80.9 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Operating cash flow: -73647000 USD · 2023-01-01 – 2023-12-31 Source
  • Operating cash flow: -54745000 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -23703000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -41741000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -23703000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -61529000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -41741000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 970000 USD · 2023-01-01 – 2023-12-31 Source
  • Capital expenditure: 578000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 25000 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 26000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 25000 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 33000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 26000 USD · 2024-01-01 – 2024-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2024-11-12.

Financial data available through: 2023-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2023-12-31
  • Operating income: 4 of 11 periods available· newest 2023-12-31
  • Net income: 4 of 11 periods available· newest 2023-12-31
  • Operating cash flow: 4 of 11 periods available· newest 2023-12-31
  • Capital expenditure: 4 of 11 periods available· newest 2023-12-31
  • Total assets: 3 of 11 periods available· newest 2023-12-31
  • Total liabilities: 3 of 11 periods available· newest 2023-12-31
  • Current assets: 3 of 11 periods available· newest 2023-12-31
  • Current liabilities: 3 of 11 periods available· newest 2023-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2023-12-31
  • Long-term debt including current maturities: 2 of 11 periods available· newest 2022-12-31
  • Shares outstanding: 3 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +280.5%

    Prior period

    USD 765,000

    –

    Current period

    USD 2.91 million

    –

    Exact inputs and evidence

    2911000 − 765000 = 2146000 USD

    765000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    2911000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −USD 3.94 million

    Prior period

    −USD 90.88 million

    –

    Current period

    −USD 94.82 million

    –

    Exact inputs and evidence

    -94820000 − -90879000 = -3941000 USD

    -90879000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -94820000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 13.45 million

    Prior period

    −USD 87.09 million

    –

    Current period

    −USD 73.65 million

    –

    Exact inputs and evidence

    -73647000 − -87094000 = 13447000 USD

    -87094000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -73647000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -83.9%

    Prior period

    USD 6.02 million

    –

    Current period

    USD 970,000

    –

    Exact inputs and evidence

    970000 − 6022000 = -5052000 USD

    6022000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    970000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

  • Revenue USD 2.91 million 100% of revenue
  • Cost of revenue USD 3.47 million 119% of revenue
  • Operating expenses USD 102.24 million 3,512% of revenue
  • Operating income −USD 102.8 million −3,531% of revenue
  • Tax, interest and other Derived −USD 7.98 million −274% of revenue
  • Net income −USD 94.82 million −3,257% of revenue

Cash

  • Operating cash flow −USD 73.65 million −2,530% of revenue
  • Capital expenditure USD 970,000 33% of revenue
  • Free cash flow Derived −USD 74.62 million −2,563% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2021 Not shown: operating income or net income is not reported.
  • 2022 Operating loss: operating costs were 12,321% of revenue.
  • 2023 Operating loss: operating costs were 3,631% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2021 2021-01-01 – 2021-12-310 61279000 Derived -61279000 37492000 Derived -98771000 -56565000 Derived
Source
2022 2022-01-01 – 2022-12-31765000 94252000 Derived -93487000 -2608000 Derived -90879000 -93116000 Derived
Source
2023 2023-01-01 – 2023-12-312911000 105712000 Derived -102801000 -7981000 Derived -94820000 -74617000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.9M 2023
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.1M2.4M1.6M786.0K0.0202120222023
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Revenue0
2022Revenue765000
2023Revenue2911000

Revenue growth

Change in revenue from the same financial period one year earlier.

280.5% 2023
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.303%227%151%76%0%202120222023
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2021Year over yearNo prior comparable period
2022Year over yearNo prior comparable period
2023Year over year280.5%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -3,531.5% 2023
Net margin -3,257.3% 2023
Free cash flow margin -2,563.3% 2023
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.978%-2,566%-6,110%-9,654%-13,198%202120222023
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2021Operating marginNot reported
2022Operating margin-12,220.5%
2023Operating margin-3,531.5%
2021Net marginNot reported
2022Net margin-11,879.6%
2023Net margin-3,257.3%
2021Free cash flow marginNot reported
2022Free cash flow margin-12,172%
2023Free cash flow margin-2,563.3%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -73.6M 2023
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7.0M-18.3M-43.5M-68.8M-94.1M202120222023
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Operating cash flow-51701000
2022Operating cash flow-87094000
2023Operating cash flow-73647000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -74.6M 2023
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7.4M-19.6M-46.6M-73.6M-100.6M202120222023
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Free cash flow-56565000
2022Free cash flow-93116000
2023Free cash flow-74617000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

32.6% 2023
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.35.2%26.4%17.6%8.8%0.0%202120222023
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2021Liabilities / assets5.5%
2022Liabilities / assets20.6%
2023Liabilities / assets32.6%

Current assets to current liabilities

Current assets divided by current liabilities.

10.51× 2023
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.55.69×41.77×27.85×13.92×0.00×202120222023
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2021Current assets / current liabilities51.57×
2022Current assets / current liabilities19.01×
2023Current assets / current liabilities10.51×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2020 2020-01-01 – 2020-12-31
−USD 27.95 million
Exact value

Exact value: -27945000 USD

2020-01-01 – 2020-12-31: -27945000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 24.87 million
Exact value

Exact value: -24873000 USD

2020-01-01 – 2020-12-31: -24873000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.38 million
Exact value

Exact value: 1380000 USD

2020-01-01 – 2020-12-31: 1380000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 26.25 million
Calculation and evidence

-24873000 − 1380000 USD

Exact free cash flow: -26253000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 98.77 million
Exact value

Exact value: -98771000 USD

2021-01-01 – 2021-12-31: -98771000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 51.7 million
Exact value

Exact value: -51701000 USD

2021-01-01 – 2021-12-31: -51701000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4.86 million
Exact value

Exact value: 4864000 USD

2021-01-01 – 2021-12-31: 4864000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 56.57 million
Calculation and evidence

-51701000 − 4864000 USD

Exact free cash flow: -56565000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 90.88 million
Exact value

Exact value: -90879000 USD

2022-01-01 – 2022-12-31: -90879000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 87.09 million
Exact value

Exact value: -87094000 USD

2022-01-01 – 2022-12-31: -87094000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 6.02 million
Exact value

Exact value: 6022000 USD

2022-01-01 – 2022-12-31: 6022000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 93.12 million
Calculation and evidence

-87094000 − 6022000 USD

Exact free cash flow: -93116000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 94.82 million
Exact value

Exact value: -94820000 USD

2023-01-01 – 2023-12-31: -94820000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 73.65 million
Exact value

Exact value: -73647000 USD

2023-01-01 – 2023-12-31: -73647000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 970,000
Exact value

Exact value: 970000 USD

2023-01-01 – 2023-12-31: 970000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 74.62 million
Calculation and evidence

-73647000 − 970000 USD

Exact free cash flow: -74617000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

20 filings · 1,144 latest values · 1,144 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001850906, 1850906, OMIC, edgar:1850906

Also known as SINGULAR GENOMICS SYSTEMS, INC., Singular Genomics Systems, Inc.